NHS Guidelines for Aciclovir Use During Pregnancy
Safety Profile During Pregnancy
According to NHS guidance, aciclovir is classified as pregnancy category B, meaning studies in animals have not shown harmful effects to the foetus. The medication has been used safely during pregnancy for over three decades, with extensive real-world data supporting its use when clinically indicated. Healthcare providers may prescribe aciclovir when the benefits outweigh potential risks, particularly for managing severe or frequent cold sore outbreaks.
Topical vs Oral Aciclovir in Pregnancy
Topical aciclovir cream represents the first-line treatment approach during pregnancy due to minimal systemic absorption. The 5% cream formulation, available through EverydayMeds, provides localised antiviral action with negligible blood levels. Oral aciclovir tablets may be considered for severe outbreaks or suppressive therapy, particularly in women with frequent recurrences that could impact quality of life or nutrition during pregnancy.
Trimester-Specific Considerations
First trimester prescribing requires careful evaluation, as this period involves crucial organ development. However, aciclovir does not appear to increase birth defect risks based on pregnancy registry data. Second and third trimester use is more commonly prescribed, with some women receiving suppressive therapy to prevent outbreaks near delivery. Healthcare providers may recommend aciclovir treatment to reduce viral shedding and transmission risks during labour.
Treatment Options Available
EverydayMeds offers several aciclovir formulations suitable for pregnancy use, including 400mg tablets and topical cream preparations. Valaciclovir represents an alternative option with improved bioavailability, though aciclovir remains the preferred choice due to longer safety experience in pregnancy. Treatment decisions should always involve consultation with prescribing healthcare providers who can assess individual circumstances and provide personalised recommendations.
